Limb girdle muscular dystrophy: A prospective follow-up study of functional impairment

Muscle and Nerve

Volumn 20, Issue 4, 1997, Pages 453-460

  Stübgen, Joerg Patrick ^a   Stipp, Annette ^b  

^a Department of Obstetrics Gynecology   (United States)

^b Lynn Med Clinic   (South Africa)

Author keywords

activities of daily living; clinical disease progression; functional grading; limb girdle muscular dystrophy; manual muscle testing

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DISABILITY; DISEASE COURSE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ACTIVITIES OF DAILY LIVING; ADULT; AGE OF ONSET; AGED; ARM; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEG; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0030992103     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199704)20:4<453::AID-MUS8>3.0.CO;2-9     Document Type: Article

References (21)

1. Appel V, Stewart SS, Smith G, Appel SH: A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987;22:328-333.
2. Bashir R, Strachan T, Keers S, Stephenson A, Mahjneh I, Marconi G, Nashef L, Bushby KMD: A gene for autosomal recessive limb-girdle muscular dystrophy maps to chromosome 2p. Hum Mol Genet 1994;3:455-457.
3. Bönneman CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, McNally EM, Duggan DJ, Angelini C, Hoffman EP, Ozawa E, Kunkel LM: Beta-sarcoglycan (A36) mutations cause autosomal recessive muscular dystrophy with loss of sarcoglycan complex. Nat Genet 1995;11:266-273.
4. Bradley WG: The limb gridle syndromes, in Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology. Amsterdam, Elsevier/North Holland, 1979, vol 40, pp 433-469.
5. Brooke MH: Introductory comments on disease-specific tests. Muscle Nerve 1990;13(suppl):38-39.
6. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA, and the CIDD Group: Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983;6:91-103.
7. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ: Clinical trial in Duchenne dystrophy: 1. The design of the protocol. Muscle Nerve 1981;4:186-197.
8. Fourgerousse F, Broux O, Richard I, Allamand V, deSouza AP, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudat C, Chiannilkulchaï N, Hillaire D, Bui H, Chumakov I, Weissenbach J, Cherif D, Cohen D, Beckman JS: Mapping of a chromosome 15 region involved in limb girdle muscular dystrophy. Hum Mol Genet 1994;3:285-293.
9. Gresham GE, Phillips TF, Labi MLC: ADL status in stroke: relative merits of three standard indexes. Arch Phys Med Rehabil 1980;16:355-358.
10. Hasselkus BR, Safrit MJ: Measurement in occupational therapy. Am J Occup Ther 1976;30:429-437.
11. Jackson CE, Strehler DA: Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease. Pediatrics 1968;41:495-502.
12. Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. Md Med J 1965;14:61-65.
13. Mendell JR, Florence J: Manual muscle testing. Muscle Nerve 1990;13(suppl):16-20.
14. Moxley RT: Functional testing. Muscle Nerve 1990;13(suppl):26-29.
15. Noguchi S, McNally EM, Othmane KB, Hagiwara Y, Mizuno Y, Yoshida M, Yamamoto H, Bönneman CG, Gussoni E, Denton PH, Kyriakides T, Middleton L, Hentati F, Hamida MB, Nonaka I, Vance JM, Kunkel LM, Ozawa E: Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995;270:819-822.
16. Piccolo F, Roberds SL, Jeanpierre M, Leturq F, Azibi K, Beldjord C, Carrie A, Recan D, Chaouch M, Reghis A, El Kerch F, Sefiani A, Voit T, Merlini L, Collin H, Eymard B, Beckman JS, Romero NB, Tomé FMS, Fardeau M, Campbell KP, Kaplan JC: Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet 1995;10:243-245.
17. Richard I, Bronx O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguiel L, Devaud C, Pasturaud P, Roudat C, Hillaire D, Passos-Bueno M-R, Zatz M, Tischfield JA, Fardeau M, Jackson CE, Cohen D, Beckman JS: Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995;81:27-40.
18. Shields RW: Limb girdle syndromes, in Engel AG, Franzini-Armstrong C (eds): Myology, 2nd ed. New York, McGraw-Hill, vol 2, pp 1258-1274.
19. Speer MC, Yamaoka LH, Gilchrist JH, Gaskell CP, Stajich JM, Vance JM, Kazantsev A, Lastra AA, Haynes CS, Beckman JS, Cohen D, Weber JL, Roses AD, Pericak-Vance MA: Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q. Am J Hum Genet 1992;50:1211-1217.
20. Speer MC, Yamaoka LH, Gilchrist JM, Westbrook C, Stajich JM, Gaskell PC, Roses AD, Pericak-Vance MA: Evidence for genetic heterogeneity in the dominant form of limb-girdle muscular dystrophy. Am J Hum Genet 1993;53A:1082.
21. Stübgen J-P: Limb girdle muscular dystrophy: description of a phenotype. Muscle Nerve 1994;127:1449-1455.